Alnylam Pharmaceuticals
Arseniy Belov is a Senior Scientist at Alnylam Pharmaceuticals, with previous experience as a Senior Scientist/Manager at Pace Analytical and Investigator at GSK. Expertise includes the characterization of protein and oligonucleotide therapeutics using various mass spectrometry techniques, as well as lipid nanoparticle analysis. Arseniy has a strong background in analytical chemistry, evidenced by a PhD from Northeastern University, where research focused on rare cell isolation and protein complex characterization. Additional roles encompass postdoctoral work on high-throughput screening platforms, laboratory technician positions, and participation in multiple internships throughout academic training and early career.
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.